SCHEMBL8398654

SCHEMBL8398654

C=C1/C(=C\C=C2CCC[C@]3(C)[C@@H]([C@H](C)C(O)CC(=O)N(C)c4ccccc4)CC[C@@H]23)C[C@H](O)C[C@H]1O

nearest known ligand 0.65

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 6/20 0.65
▸ CYP24A1 Q07973 4/20 0.61
▸ CYP27B1 O15528 1/20 0.59
▸ ADORA3 P0DMS8 2/20 0.57
▸ SLC6A2 P23975 2/20 0.57
▸ NR1I2 O75469 1/20 0.57
▸ PGR P06401 1/20 0.57
▸ HTR1A P08908 1/20 0.57
▸ SLC6A4 P31645 1/20 0.57
▸ ADRA1A P35348 1/20 0.57
▸ PTGS2 P35354 1/20 0.57
▸ AGTR1 P30556 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8398613 0.89 VDR (0.70) VDRCYP24A1ADORA3SLC6A2NR1I2
SCHEMBL8398764 0.88 VDR (0.70) VDRCYP24A1ADORA3SLC6A2NR1I2
SCHEMBL8397620 0.87 VDR (0.69) VDRADORA3SLC6A2NR1I2PGR
SCHEMBL11329344 0.80 VDR (0.79) VDRCYP24A1ADORA3SLC6A2NR1I2
SCHEMBL11329349 0.80 VDR (0.79) VDRCYP24A1ADORA3SLC6A2NR1I2
SCHEMBL8400480 0.79 VDR (0.69) VDRADORA3SLC6A2NR1I2PGR
SCHEMBL11442771 0.79 VDR (1.00) VDRCYP24A1ADORA3SLC6A2NR1I2
SCHEMBL1249405 0.79 VDR (1.00) VDRCYP24A1ADORA3SLC6A2NR1I2
SCHEMBL10942369 0.79 VDR (0.72) VDRADORA3SLC6A2NR1I2PGR
SCHEMBL10942373 0.79 VDR (0.72) VDRADORA3SLC6A2NR1I2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0751932-B1 VITAMIN-D AMIDE DERIVATIVES RES INST MEDICINE CHEM (US) 1999-06-09 — — EP disclosed
US-5811562-A Vitamin-D amide derivatives RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) 1998-09-22 — — US disclosed
Send feedback